Comparing the effects of Platelet-rich plasma (PRP) with Corticosteroid injection in resistant tennis Elbow patients to non-surgical treatment
- Conditions
- Lateral epicondylitisM77.1ateral epicondylitis.
- Registration Number
- IRCT20191105045335N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 36
Patients diagnosed with lateral epicondylitis and related functional impairments after six weeks of *non - surgical care such as resting, avoiding severe activities, Behavior reform, physical therapy, Non Steroid Anti Inflammatory Drug (NSAID)
In physical examination, resisted wrist extension test in forearm pronation and elbow extension, VAS score=5 or more symptoms lasting for at least 3 months
Age of 70 years old or more
History of infectious diseases or fever in recent days
History of any malignancies
Diagnosed carpal tunnel syndrome or any other peripheral nerve lesions or cervical radiculopathy
Systemic diseases such as ischemic heart disease, diabetes mellitus, rheumatoid arthritis or hepatitis
Any bone malformations or bone injuries in humerus or elbow joint
History of autoimmune diseases
History of Platelet dysfunction
using anti platelet medications during last 10 days or using NSAIDs during last 48 hours before injection
Using steroids during last 3 weeks
Hb=10 or less
patients with platelet count less than 150000
History of vasovagal reaction
Pregnency or breast feeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: before injection, 2week ,1 and 3 months after injection. Method of measurement: Visual analogue scale (VAS).;Function. Timepoint: before injection, 2week ,1 and 3 months after injection. Method of measurement: Disabilities of the Arm, Shoulder and Hand (DASH) score.
- Secondary Outcome Measures
Name Time Method Side effects of injection. Timepoint: 2week,1 and 3 months after injection. Method of measurement: Clinical examination.